Xtalks presents a live webinar on conducting successful biosimilar trials. Xtalks is offering two live broadcast on Tuesday March 19, 2013 at 4pm KST (South Korea) and 11am EST (N. America).
The expiration of patents and other intellectual property rights for originator biologics over the next decade opens up opportunities for biosimilars to enter the market and increase competition. Despite the challenges associated with biosimilar drug development, many drug manufacturers are entering the race to develop biosimilars — especially for blockbuster mAbs. With increased clinical trial activity through Phase III, the ability to recruit patients into these important studies becomes a key stepping stone to biosimilar commercial success.
The speaker will be Rodeina Challand, Executive Director of Biosimilars Development at PRA and a Q&A with the audience will follow the main presentation.
For more information about this event or to register, visit: http://xtks.in/xto565-event